3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
3
Rhabdomyosarcoma, Embryonal
3
Rhabdomyosarcoma
3
Rhabdomyosarcoma, Alveolar
2
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Pleuropulmonary blastoma
1
Histiocytoma, Malignant Fibrous
1
Dermatofibrosarcoma
1
Beckwith-Wiedemann Syndrome
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Dactinomycin
×
90 days
×
Clear all
No trials found.